Evaluation of the combined effect of nasal midazolam/ketamine on sedation of 3-6 years non-cooperative pediatric dentistry

Phase 3

• Conditions: Anxiety.; Anxiety disorder due to known physiological condition; F06.4

• Registration Number: IRCT20090506001882N9
• Lead Sponsor: Shahid Beheshti University of Medical Sciences

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Last Update Posted: 9 November 2020

Recruitment & Eligibility

• Status: Complete
• Sex: All
• Target Recruitment: 20

Inclusion Criteria

Be in the negative group be Frankel's behavioral classification.
Requires at least 2 similar treatment sessions .
Be in the ASAI group.
Be 3 to 6 years old.

Exclusion Criteria

Suffering Systemic Disease.
Colds during in treatment session.
Non-prescription medication including allergies and treatment needs different from protocol

Study & Design

• Study Type: interventional
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Conscious sedation. Timepoint: Every 15 minutes. Method of measurement: Houpt scale.

Secondary Outcome Measures

Name	Time	Method
SpO2. Timepoint: Every 15 minutes. Method of measurement: pulse oxymeter.